Is Apple Working on a Mobile Medical Device? - Analyst Blog
Reportedly, Apple ( AAPL ) is working on a technology that will be able to warn about a heart attack based on the sound of blood flowing through the arteries. This sensor could well be part of Apple's wearable device, referred to as iWatch and will monitor both heart beat and blood oxygen level.
The device will alert users and thus a heart attack can be
prevented with timely medical intervention. As per Verge, Apple
is collaborating with audio engineer Tomlinson Holman to develop
the heart attack predicting device.
As per reports, Apple will use optoelectronics to monitor the user's body glucose levels. Optoelectronics makes good usage of the light passing through the body as a non-invasive means of regulating health.
Last month, The New York Times reported that Apple has had discussions with the Food and Drug Administration regarding mobile medical applications. Although this further added fuel to the ongoing rumors, there has been no official confirmation from Apple on the latest development of the wearable device.
The iWatch will help Apple to step into the world of wearable devices following the footsteps of its competitor Google ( GOOG ).
We believe that Apple's intention to extend its foothold into new product categories such as healthcare and cars in the near term will drive growth and profitability going forward.
Apple's loyal customer base, international expansion, competitive pricing strategy and a solid cash position will aid long-term growth. However, increasing competition from the likes of Google, Hewlett-Packard ( HPQ ), Microsoft ( MSFT ) in most of its major product segments, possible delays in product launch, higher operating expenses and increasing legal complexities are headwinds.
Currently, Apple has a Zacks Rank #3 (Hold).
APPLE INC (AAPL): Free Stock Analysis Report
GOOGLE INC-CL A (GOOG): Free Stock Analysis Report
HEWLETT PACKARD (HPQ): Free Stock Analysis Report
MICROSOFT CORP (MSFT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research